Crestor Oral Tablet 10Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Crestor: Oral tablet (10mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_8826.JPG
Crestor 10mg Tab
AstraZeneca Pharmaceuticals LP
Pill Identification: CRESTOR 10,ZD4522 10 
Drug Image file DrugItem_8826.JPG
Crestor 10mg Tab
AstraZeneca Pharmaceuticals LP
Pill Identification: CRESTOR 10,ZD4522 10 

What is this Medicine?

ROSUVASTATIN (roe SOO va sta tin) is known as a HMG-CoA reductase inhibitor or 'statin'. It lowers cholesterol and triglycerides in the blood. This drug may also reduce the risk of heart attack, stroke, or other health problems in patients with risk factors for heart disease. Diet and lifestyle changes are often used with this drug.

CVS Pharmacy Patient Statistics for Crestor: Oral tablet(10mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Crestor 10mg Tablet

NDC: 003100751
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Hyperlipoproteinemia, Hypercholesterolemia, Myocardial Infarction Prophylaxis, Hypertriglyceridemia, Atherosclerosis, Stroke Prophylaxis

Storage Information
Protect from moisture
Store at controlled room temperature (between 68 and 77 degrees F)
Crestor 10mg Tablet
Drug Image file DrugItem_6360.JPG
AstraZeneca Pharmaceuticals LP
Pill Identification: CRESTOR 10,ZD4522 10 
Shape: round
Color: pink
Drug Image file DrugItem_8826.JPG
AstraZeneca Pharmaceuticals LP
Pill Identification: CRESTOR 10,ZD4522 10 
Shape: round
Color: pink

Reported Side Effects for Crestor 10mg Tablet

Low White Blood Cell Counts Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Immune-mediated Necrotizing Myopathy Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Angioedema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Low Platelet Count Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Itching Incidence:
>1.0%*
Severity: MILD
Onset: RAPID
Elevated Hepatic Enzymes Incidence:
1.1-2.2%*
Severity: MODERATE
Onset: DELAYED
Protein In The Urine Incidence:
1.3%*
Severity: SEVERE
Onset: DELAYED
Blood In The Urine Incidence:
1.3%*
Severity: MODERATE
Onset: DELAYED
Skin Rash Incidence:
>2.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
2.4-3.4%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
2.4%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
2.4-3.3%*
Severity: MODERATE
Onset: DELAYED
Weakness Incidence:
2.7%*
Severity: MILD
Onset: DELAYED
Muscle Pain Incidence:
2.8-12.7%*
Severity: MILD
Onset: EARLY
Diabetes Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
3.4%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
3.4%*
Severity: MILD
Onset: EARLY
Joint Pain Incidence:
3.8-10.1%*
Severity: MILD
Onset: DELAYED
Lightheadedness Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
5.5-6.4%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

SECOND Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

THIRD Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Crestor

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.